Subtle Medical secured $33 million to accelerate its AI image enhancement solutions for radiology.
Key Details
- 1Subtle Medical raised $33 million in growth capital, bringing total funding to approximately $86 million.
- 2The funding was led by Morgan Stanley Expansion Capital, with participation from several new and existing investors.
- 3Subtle's AI solutions (SubtleHD(MR) for MRI, and SubtlePET for PET) speed up scan times while maintaining image quality.
- 4SubtlePET received FDA 510(k) clearance in May and can reduce PET scan times by up to 75%.
- 5The technology is deployed on about 1,300 scanners worldwide, across major institutions like Mount Sinai and RadNet.
Why It Matters
Expanded funding allows Subtle Medical to further develop and deploy its vendor-neutral AI solutions, enhancing efficiency and patient throughput across radiology departments globally. Rapid scan times and improved imaging quality are key benefits for healthcare providers adopting AI technologies.
Source
Radiology Business
Related News
•Radiology Business
RadNet AI Tool Reduces Unnecessary Prostate Biopsies by 19%
RadNet's DeepHealth AI tool can help avoid nearly 1 in 5 prostate biopsies while maintaining high cancer detection sensitivity.
•Radiology Business
FDA Clears MRI2CT AI for 3D Bone Visualization from MRI
MRI2CT's NextMR receives FDA clearance to generate 3D bone images from standard spine MRIs, reducing reliance on CT scans.
•Radiology Business
FDA Clears AIRS Medical AI for Rapid MRI Body Composition Analysis
AIRS Medical's SwiftSight Body Composition AI software receives FDA 510(k) clearance for automated MRI-based body composition reporting.